Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first‐line anti‐programmed death‐1 monotherapy: A real‐world multicentre observational cohort study
Ochenduszko, Sebastian, García Sanchez, Javier, Fita, María José Juan, González‐Barrallo, Inés, Herrero Colomina, Julio, Mujika, Karmele, Beveridge, Roberto Diaz, Martínez, Silverio Ros, Lafuente, Blanca Sánchez, Tomas, Alberto Cunquero, Jaime, Alfonso Berrocal, Cerezuela Fuentes, Pablo, Fra, Pablo Luna, Peeters, Alicia Gervás, Meana García, José Andrés, García, María Asunción Algarra, Altozano, Javier Perez, Cancela, Maria, Puchades, Almudena Mateu, Roca, Francisco Ferrando, Maiques, Inmaculada Maestu
Published in Pigment cell and melanoma research (01.09.2023)
Published in Pigment cell and melanoma research (01.09.2023)
Get full text
Journal Article
Real-world study on characteristics of advanced melanoma patients with sustained complete response (CR) after elective 1 st line anti-programmed death-1 (anti-PD1) monotherapy discontinuation
Ochenduszko, Sebastian, García, Javier, Juan-Fita, María Jose, Gonzalez-Barrallo, Ines, Herrero Colomina, Julio, Diaz Beveridge, Robert, Ros Martinez, Silverio, Sanchez Lafuente, Blanca, Cunquero Tomas, Alberto Jacobo, Berrocal, Alfonso, Cerezuela-Fuentes, Pablo, Luna Fra, Pablo, Gervás Peeters, Alicia, Sanchez Gonzalez, José Luis, Meana Garcia, Andres, Algarra Garcia, Mariasun, Palomares García, Eugenio, Perez Altozano, Javier, Tallón Guerola, Mónica, Maestu, Inmaculada
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article